NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY;KYOWA HAKKO KIRIN CO., LTD.
发明人:
Seiji Yano,Yusuke Machino,Yui Suzuki
申请号：
US14097294
公开号：
US09066929B2
申请日:
2013.12.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to a therapeutic method and a diagnostic method using an antibody that binds to a ganglioside GM2 antigen, and a therapeutic agent and a diagnostic agent comprising as an active ingredient an antibody that binds to a ganglioside GM2 antigen. According to the present invention, the prognosis of GM2 positive mesothelioma patients can be improved by diagnosing and treating GM2 positive mesothelioma patients with a diagnostic agent and a therapeutic agent that comprise an anti-ganglioside GM2 antibody as an active ingredient.
